Search hospitals > Oregon > Portland

Kaiser Permanente Northwest

Claim this profile
Portland, Oregon 97227
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Colorectal Cancer
135 reported clinical trials
3 medical researchers
Photo of Kaiser Permanente Northwest in PortlandPhoto of Kaiser Permanente Northwest in PortlandPhoto of Kaiser Permanente Northwest in Portland

Summary

Kaiser Permanente Northwest is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer and other specialties. Kaiser Permanente Northwest is involved with conducting 135 clinical trials across 314 conditions. There are 3 research doctors associated with this hospital, such as Abdul Hai Mansoor, Sandeep Mashru, and Gloria Coronado.

Area of expertise

1Cancer
Global Leader
Kaiser Permanente Northwest has run 45 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III
2Lung Cancer
Global Leader
Kaiser Permanente Northwest has run 28 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III

Top PIs

Clinical Trials running at Kaiser Permanente Northwest

Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Cancer
Colorectal Cancer
Pancreatic Cancer
Recurrence
Renal Cell Carcinoma
Multiple Myeloma
Squamous Cell Carcinoma
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Sotorasib

for Non-Small Cell Lung Cancer

This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Kaiser Permanente Northwest?
Kaiser Permanente Northwest is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer and other specialties. Kaiser Permanente Northwest is involved with conducting 135 clinical trials across 314 conditions. There are 3 research doctors associated with this hospital, such as Abdul Hai Mansoor, Sandeep Mashru, and Gloria Coronado.